---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件（201191418145618.pdf）的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文Exovate N处方资料（仅供参考）

CLOBETASOL氯倍他索：为强效糖皮质激素外用制剂，具有抗炎、抗过敏、抗增生、免疫抑制作用。临床上用于治疗银屑病、湿疹、足部干裂、斑状秃发、神经性皮炎、掌跖脓疱病等皮肤疾病。本品不宜长期、大量使用。
用于接触性皮炎、神经性皮炎、脂溢性皮炎、湿疹、盘状红斑狼疮等。

NEOMYCIN新霉素：一种抗生素，与链霉素、卡那霉素，庆大霉素同属于氨基糖苷类抗生素。它由弗氏链霉菌产生；对革兰氏阳性和阴性菌皆有效，产品主要为新霉素B和C的混合物。新霉素与卡那霉素有完全交叉抗药性，与链霉素有部分交叉抗药性；与同类抗生素类似，具有肾毒性和内耳毒性，它对内耳的伤害，往往是不可逆转的。现在这种抗生素实际已不再使用。
用于结肠手术前准备、肝昏迷时作为辅助治疗。新霉素不宜用于全身性感染的治疗。本品对绿脓杆菌无效。
 
NYSTATIN制霉菌素：是一种多烯型抗生素，分子式C47H75NO17。1950年发现土壤微生物Streptomyces noursei能分泌一种抗霉菌的物质，从而发现了第一种抗霉菌的抗生素。制霉菌素具有共轭多烯大环内酯结构，能抑制真菌和皮藓菌的活性，对细菌无抑制作用。
用于口服治疗消化道念珠菌肠炎；局部应用治疗口腔念珠菌感染、皮肤粘膜念珠菌感染。阴道念珠菌病。

Exovate N
( Clobetasol Propionate, Neomycin Sulfate and Nystatin Cream )
Clobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific antiinflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. The use of Nystatin in the local treatment of candidal infections of the skin and of Neomycin as a broad-spectrum antibiotic is well known.Exovate ®N cream is indicated in more resistant dermatoses such as recalcitrant eczemas and psoriasis (excluding widespread plaque psoriasis) where secondary bacterial or candidal infection is present, suspected or likely to occur, as when using occlusive dressings.
■Effective against non-responsive dermatoses
■Effective against allergic and pruritic conditions
■Effective against bacterial and fungal skin infections

Product Name:EXOVATE N CREAM

Registration No.:HK-55423

Certificate Holder:EUGENPHARM INTERNATIONAL LTD

Certificate Holder Address:UNIT 6A CHUAN YUAN FACTORY BLDG,
342-344 KWUN TONG RD KWUN TONG,KLN

Ingredients:           
CLOBETASOL
NEOMYCIN
NYSTATIN

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件（201191418145618.pdf）的“原文Priscribing Information”为准
---------------------------------------------------------------